About the Onsemble Community Forum

The Onsemble Community Forum is your central hub to connect, collaborate, and grow with clinical research professionals who rely on Advarra's suite of technology solutions. Created for research teams at academic medical centers, cancer centers, health systems, and other leading institutions, the forum brings peers and Advarra experts together for meaningful, product-focused discussions. Members can access product documentation and updates, release notes, on-demand webinars, and details about upcoming events and collaboration calls. By joining, you’ll stay informed, share expertise, and strengthen research operations alongside a community advancing clinical research every day.

Advarra Winter Office Closure

Please be advised that Advarra’s offices will be closed from 3:00 pm local time on Wednesday, December 24 through Thursday, January 1. If you need support during this time, please submit a support ticket and your request will be triaged and responded to beginning Friday, January 2.

Onsemble 2026 Registration is Open

Join us in Orlando April 13–17 for the 2026 Onsemble Conference. Get ready for four inspiring days filled with learning, ideas, and community.

Learn More

Welcome to the Onsemble Community!

It looks like you're new here. Sign in or register to get started.

In the news

Advarra Expands Study Collaboration Solution, Connecting Leading Clinical Trial Technology Partners to Simplify Site Access
New integrations with industry leaders in EDC, eConsent, IRT/RTSM, eCOA, payments, and patient engagement expands Advarra’s connected ecosystem, giving sponsors, The post Advarra Expands Study Collaboration Solution, Connecting Leading Clinical Trial Technology Partners to Simplify Site Access appeared first on Advarra.
Beyond the Breakthrough: Navigating the realities of CAR-T cell oncology trials
Beyond the Breakthrough explores the challenges of CAR-T oncology trials, from complex logistics and safety risks to the critical role of cross-disciplinary coordination in delivering personalized cancer therapies. The post Beyond the Breakthrough: Navigating the realities of CAR-T cell oncology trials appeared first on Advarra.
Navigating AI in Clinical Trials: Insights from Advarra’s Laura Russell
Advarra has launched the Council for Responsible AI in Clinical Trials to ensure the ethical use of AI in clinical The post Navigating AI in Clinical Trials: Insights from Advarra’s Laura Russell appeared first on Advarra.
Clinical Trials Get A Council For AI Oversight
You can’t throw a rock in clinical research right now without hitting someone pitching some new AI-enabled app, solution, process The post Clinical Trials Get A Council For AI Oversight appeared first on Advarra.
Gene Therapy Successes in Ophthalmology
Ophthalmology is quietly becoming gene therapy’s next big frontier. Here’s how the science, the patients, and the regulations are aligning. The post Gene Therapy Successes in Ophthalmology appeared first on Advarra.
The Latest Advancements in Single Sign-On Technology
Stuart Cotter dives in how today’s single sign-on reduces site burden and spearheads clinical system interoperability. The post The Latest Advancements in Single Sign-On Technology appeared first on Advarra.
The “One-and-Done” PI & Measuring the Current Site Landscape
Advarra’s Elisa Cascade joins other industry leaders, SCRS’ Jimmy Bechtel, Advarra’s Elisa Cascade, Tufts Center for the Study of Drug The post The “One-and-Done” PI & Measuring the Current Site Landscape appeared first on Advarra.
Clinical Research Trends to Expect in 2025: More Complex, Less Connected
Christine Senn digs into the results of Advarra’s Site-Sponsor-CRO Collaboration survey to reveal some new trends to expect in the The post Clinical Research Trends to Expect in 2025: More Complex, Less Connected appeared first on Advarra.
A balancing act: Innovating IRBs for the future of pediatric oncology research
Advarra deep-dives into special considerations needed for high-quality and sensitive pediatric oncology trial IRB reviews. The post A balancing act: Innovating IRBs for the future of pediatric oncology research appeared first on Advarra.
The Broken Site Feasibility Process – Could CROs Be the Fixers?
Advarra’s Christine Senn discusses compelling data from a recent site feasibility survey, the opportunity for CROs, and potential impact on The post The Broken Site Feasibility Process – Could CROs Be the Fixers? appeared first on Advarra.

View All